Keep Me Logged In
Scott Gottlieb, AEI resident fellow, and Sam Waksal, Kadmon Corporation, discuss the controversy surround the price hikes of Mylan's EpiPen and the problems that arise when companies obtain monopolies on certain drugs.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by